- All sections
- C - Chemistrymetallurgy
- C07D - Heterocyclic compounds
- C07D 207/277 - Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
Patent holdings for IPC class C07D 207/277
Total number of patents in this class: 145
10-year publication summary
|
8
|
8
|
15
|
6
|
8
|
3
|
10
|
8
|
7
|
7
|
| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| FMC Corporation | 845 |
21 |
| Novartis AG | 10744 |
8 |
| Merck Patent GmbH | 5815 |
7 |
| California Institute of Technology | 3977 |
7 |
| Theravance Biopharma R&D IP, LLC | 456 |
5 |
| Bristol-myers Squibb Company | 4880 |
4 |
| E. I. du Pont de Nemours and Company | 4050 |
4 |
| Clariant Finance (BVI) Limited | 386 |
4 |
| The Lubrizol Corporation | 1288 |
4 |
| Hoffmann-La Roche Inc. | 3439 |
3 |
| Boehringer Ingelheim International GmbH | 4642 |
3 |
| Eli Lilly and Company | 3848 |
3 |
| GL Chemtec Vision Inc. | 7 |
3 |
| L' Oréal | 5536 |
3 |
| Lilly China Research and Development Co., Ltd. | 41 |
3 |
| Janssen Pharmaceutica N.V. | 3394 |
2 |
| Syngenta Crop Protection AG | 6074 |
2 |
| Bayer AG | 3325 |
2 |
| Massachusetts Institute of Technology | 10062 |
2 |
| ADAMA Agan Ltd. | 375 |
2 |
| Other owners | 53 |